Ireland· IE-PA-PA25384/001/001
Minreksav 1.5 mg/pump actuation oral solution
A cytisinicline product containing cytisinicline, registered in Ireland by Profit Sylwia Gil. The same ATC class is registered in 9 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Cytisinicline is registered in 9 of 19 countries.
Countries holding a registration under ATC N07BA04 (cytisinicline), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 4 of them publish a price we can compare per daily dose
Cytisinicline · ATC N07BA04
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Cytisinicline
- Manufacturer
- Profit Sylwia Gil
- Country
- Ireland (IE)
- ATC code
- N07BA04
- ATC class
- Cytisinicline
- Defined daily dose
- 6 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA25384/001/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cytisinicline in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandBelnifremAPC Pharmlog Sp. z o.o.
- SpainGLAVRINXA 1,5 MG/DOSIS SOLUCIÓN ORALNewline Pharma S.L.U.
- CzechiaDEFUMOXANAflofarm Farmacja Polska Sp. z o.o., Pabianice
- SwedenAsmoken 1,5 mg TablettOrifarm AB
- NetherlandsCytisinicline Medcor 1,5 mg, tablettenMedcor Pharmaceuticals B.V.
- United KingdomBelnifrem 1.5mg tabletsViatris UK Healthcare Ltd
- GermanyAsmokenAflofarm Farmacja Polska Sp. Z O.O.
- BelgiumDecigatan 1.5 mgAflofarm Farmacja Polska
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Asmoken, Recigar
- Belgium · Decigatan
- Bulgaria · Liberizin, Никитабс
- Cyprus · Cytisinicline Uni-Pharma
- Czechia · Defumoxan, Heavis
- Germany · Asmoken, Cytisiniclin Apc Pharmlog
- Denmark · Decigatan
- Spain · Belnifrem, Glavrinxa
- Finland · Cysarax
- France · Liberostin
- United Kingdom (Northern Ireland) · Belnifrem, Cytisinicline Adamed
- Greece · Liberizin, Tokovys
- Hungary · Liberisan
- Italy · Citisiniclina Adamed, Defucitan
- Lithuania · Tabex
- Latvia · Tabex
- Malta · Novynta
- Netherlands · Decigatan
- Norway · Cysarax
- Poland · Belnifrem, Cerdablan
- Portugal · Dextazin, Recigarum
- Romania · Defumoxan, Fumix
- Sweden · Belnifrem, Cysarax
- Slovakia · Defumoxan, Heavis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c6c52a1e-90a6-415b-9e35-7825d2f6f94f GET /v1/drugs/c6c52a1e-90a6-415b-9e35-7825d2f6f94f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oral solution",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"N07BA04"
],
"strength": null,
"pa_number": "PA25384/001/001",
"substances": [
"Cytisinicline"
],
"legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "27/02/2026",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about cytisinicline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.